We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EOG:NYSEEOG Resources, Inc. Analysis

Data as of 2026-05-20 - not real-time

$141.63

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

EOG Resources is trading at $141.63, comfortably above its 20‑day ($137.01) and 50‑day ($137.68) moving averages and the 200‑day ($119.04) trend line, while the MACD remains bullish and the RSI sits at 58, indicating modest upward momentum. The stock trades near the upper end of its technical range (resistance $145.70, support $128.83) and commands a forward P/E of 9.9 versus an industry average of 21.7, suggesting relative cheapness. A dividend yield of 2.83% with a 39% payout ratio is underpinned by robust operating cash flow ($10.7 B) and a low debt‑to‑equity of 27%, though the DCF fair value ($123.24) is below the current price, implying a modest premium.
Recent Q1 results beat estimates, driven by higher crude prices and a strategic shift toward oil‑weighted assets, reinforcing the bullish fundamentals. However, analysts note a tepid outlook and the stock’s 30‑day volatility of ~31% adds short‑term uncertainty. The extreme‑greed sentiment (FGI 90) and a negative beta (-0.28) temper risk, while the company’s U.S.‑centric geography and stable liquidity keep broader risks moderate.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish technical positioning near resistance
  • Earnings beat but cautious forward outlook
  • Elevated short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Attractive valuation versus peers
  • Strong cash generation and sustainable dividend
  • Analyst consensus target above current price

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Solid balance sheet with low leverage
  • Strategic shift toward higher‑margin oil assets
  • Long‑term energy demand supporting stable earnings

Key Metrics & Analysis

Financial Health

Revenue Growth15.60%
Profit Margin23.32%
P/E Ratio13.9
ROE18.20%
ROA8.97%
Debt/Equity26.87
P/B Ratio2.5
Op. Cash Flow$10.7B
Free Cash Flow$2.9B
Industry P/E21.7

Technical Analysis

TrendNeutral
RSI58.0
Support$128.83
Resistance$145.70
MA 20$137.01
MA 50$137.68
MA 200$119.04
MACDBullish
VolumeStable
Fear & Greed Index90.29

Valuation

Fair Value$123.24
Target Price$157.50
Upside/Downside11.21%
GradeFair
TypeBlend
Dividend Yield2.83%

Risk Assessment

Beta-0.28
Volatility30.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.